Riskpilot← Back to searchSign inGet full accessTFS International Clinical Development Services AB
ABActiveOrg 5590396452Economic activity was not specified by tax authority · NACE 0000Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
99.9%
Financial strength
Net profit 2024
SEK 52,6M
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -34K | — |
| Net profit | SEK 52,6M | — |
| Total assets | SEK 455,2M | +4% |
| Equity | SEK 454,9M | +5% |
| Employees | 0 | — |
Legal name
TFS International Clinical Development Services AB
Org number
5590396452
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
8 december 2015
Share capital
SEK 57 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att fungera som moderbolag åt där dotterbolagen på konsultbasis planerar, koordinerar, genomför samt avslutar och avrapporterar kliniska prövningar inom \lifescience\-industrin och därmed förenlig verksamhet.
Address
Phone
+46462801800
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | −31 | −145 | — | −34 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −31 | −145 | 0 | −34 |
| Net financials | — | −944 | 1 112 | — | 52 827 |
| Profit before tax | 0 | −974 | 968 | 0 | 52 803 |
| Tax | −0 | −0 | −189 | −0 | −252 |
| Net profit | 0 | −974 | 779 | 0 | 52 551 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 313 150 | 318 631 | 386 772 | 437 338 | 455 174 |
| Equity | 310 782 | 316 488 | 344 175 | 434 009 | 454 911 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 368 | 2 142 | 35 512 | 0 | 252 |
| Total debt | 2 368 | 2 142 | 35 512 | — | 252 |
EBITDA margin
-3400000.0%
This company
15.8%
Market median
-21519087% vs market
20202024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
11.6%
This company
18.4%
Market median
+37% vs market
20202024
Net profit margin
5255100000.0%
This company
8.1%
Market median
+64877777678% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AF Chief Auditor | Chief Auditor | 2022 |
| Former (3) | ||
JF Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
AS Chief Auditor | Chief Auditor | 2020 – 2022 |
MT Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (6) | ||
| Board of Directors | 2021 – 2022 | |
| Chairman | 2020 – 2021 | |
| Chairman | 2021 – 2025 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ratos Ind. ABTFS Trial Form Support International ABTFS International Financial Services AB
TFS International Clinical Development Services AB (this company)Tfs Trial Form Support BvTfs Trial Form Support ASTfs Trial Form Support OuTfs Trial Form Support KftTfs Trial Form Support Canada IncAppletree Ci Group AgTfs Trial Form Support Sp Z.O.oTfs Holdings Us IncTfs Trial Form Support GmbhTfs Trial Form Support AgTfs Trial Support S.R.L.Tfs Trial Form Support S.R.oTfs Trial Form Support ApsTfs Trial Form Support Ltd IsraelTfs Trial Support S.L.Tfs Trial Form Support SasTfs Trial Form Support LtdTfs Trial Form Support CzechTfs Trial Form Support OyTFS TRIAL SUPPORT S.R.L.TFS TRIAL FORM SUPPORT SP Z.O.OTFS TRIAL FORM SUPPORT CANADA INCTFS TRIAL FORM SUPPORT APSTFS HOLDINGS US INCTFS TRIAL FORM SUPPORT SASTFS TRIAL FORM SUPPORT AGTFS TRIAL FORM SUPPORT BVTFS TRIAL FORM SUPPORT CZECHTFS TRIAL FORM SUPPORT ASTFS TRIAL FORM SUPPORT GMBHTFS TRIAL FORM SUPPORT LTDTFS TRIAL FORM SUPPORT LTD ISRAELTFS TRIAL FORM SUPPORT KFTTFS TRIAL SUPPORT S.L.TFS TRIAL FORM SUPPORT OYBoard members of TFS International Clinical Development Services AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Fredrik Rodéhn | Chief Auditor | 0 companies |
| Jan Filakovsky | Chief Executive Officer | 0 companies |
| Anders Sture Kriström | Chief Auditor | 0 companies |
| Magnus Thor Hannesson Stephensen | Chief Executive Officer | 0 companies |
| René Holmen Pedersen | Board of Directors | 0 companies |
| Per Gösta Magnusson | Chairman | 0 companies |
| Patrik Mikael Polo Darsund | Deputy Board Member | 0 companies |
| Bassem Radwan Saleh | Chairman | 0 companies |
| Nina Henriette Holst | Board of Directors | 0 companies |
| Andreas Joakim Björndalen Twetman | Board of Directors | 0 companies |
| Jonas Olof Wiström | Board of Directors | 0 companies |
| Jesper Hjort | Board of Directors | 0 companies |